The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Antipsychotic Use in Dementia: Is There a Problem and Are There Solutions?
Open accessAbstract
Antipsychotics are necessary for many older adults to treat major mental illnesses or reduce distressing psychiatric symptoms. Current controversy exists over the role of antipsychotics in the management of neuropsychiatric symptoms (NPS) in persons with dementia. Although some NPS may be appropriately and safely treated with antipsychotics, a fine balance must be achieved between the benefits of these medications, which are often modest, and adverse events, which may have significant consequences. Approximately one-third of all persons with dementia are currently prescribed antipsychotic medications, and there is significant variation in the use of antipsychotics across care settings and providers. Reducing the inappropriate or unnecessary use of antipsychotics among persons with dementia has been the focus of increasing attention owing to better awareness of the potential problems associated with these medications. Several approaches can be used to curb the use of antipsychotics among persons with dementia, including policy or regulatory changes, public reporting, and educational outreach. Recently, there has been encouraging evidence of a downward trend in the use of antipsychotics in many long-term care settings, although prescribing rates are still higher than what is likely optimal. Although reducing the inappropriate use of antipsychotics is a complex task, psychiatrists can play an important role via the provision of clinical care and research evidence, contributing to improved care of persons with dementia in Canada and elsewhere.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, communication around new or modified use of antipsychotic medications during hospitalization may provide subsequent caregivers with critical knowledge on the therapeutic benefits, or lack thereof, for the patient with dementia which can inform later care management strategies.30, 45”
From Discharge Communication of Dementia-Related Neuropsychiatric Symptoms and Care Management Strategies during Hospital to Skilled Nursing Facility Transitions (2021) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Audit and feedback: effects on professional practice and healthcare outcomes
Ivers, N., Jamtvedt, G., Flottorp, S., Young, J. M., Odgaard-Jensen, J., French, S. D., O'Brien, M. A., Johansen, M., Grimshaw, J., & Oxman, A. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub3 · Cited by 5,485 · cited 1×
“There is evidence suggesting that public reporting may be more effective in influencing changes at organizational and administrative levels, rather than at the level of individual providers or patients.(105,107) Starting in 2015, CIHI has provided publicly reported antipsychotic prescribing at the level of individual…”
BackgroundCanadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,730
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Fung, C. H., Lim, Y.-W., Mattke, S., Damberg, C. L., & Shekelle, P. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00006 · Cited by 981
Schneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
The Public Release of Performance Data
Marshall, M., Shekelle, P., Leatherman, S. T., & Brook, R. H. (2000) · JAMA · doi:10.1001/jama.283.14.1866 · Cited by 846
Connections Between Quality Measurement and Improvement
Berwick, D. M., James, B. C., & Coye, M. J. (2003) · Medical Care · doi:10.1097/00005650-200301001-00004 · Cited by 578
Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., Gill, R., Juszczak, E., Yu, L.-M., & Jacoby, R. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70295-3 · Cited by 567
Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Jibson, M. D., Lopez, O. L., Mahoney, J., Pasic, J., Tan, Z. S., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.173501 · Cited by 441
Selbæk, G., Kirkevold, Ø., & Engedal, K. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1749 · Cited by 369
Sultzer, D. L., Davis, S. M., Tariot, P. N., Dagerman, K. S., Lebowitz, B. D., Lyketsos, C. G., Rosenheck, R. A., Hsiao, J. K., Lieberman, J. A., Schneider, L. S., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111779 · Cited by 321
A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.
Ray, W. A., Federspiel, C. F., & Schaffner, W. (1980) · American Journal of Public Health · doi:10.2105/ajph.70.5.485 · Cited by 298
Vigen, C. L. P., Mack, W. J., Keefe, R. S. E., Sano, M. C., Sultzer, D. L., Stroup, T. S., Dagerman, K., Hsiao, J., Lebowitz, B. D., Lyketsos, C. G., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.08121844 · Cited by 285
Schnaider Beeri, M., Werner, P., Davidson, M., & Noy, S. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.490 · Cited by 284
Comorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?
Schubert, C. C., Boustani, M. A., Callahan, C. M., Perkins, A. J., Carney, C. P., Fox, C., Unverzagt, F. W., Hui, S. L., & Hendrie, H. C. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00543.x · Cited by 283
Zuidema, S. U., Derksen, E. W. C., Verhey, F. R. J., & Koopmans, R. T. C. M. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1722 · Cited by 275
Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges
Crystal, S., Olfson, M., Huang, C., Pincus, H. A., & Gerhard, T. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.w770 · Cited by 270
Hawes, C., Mor, V., Phillips, C. D., Fries, B. E., Morris, J. N., Steele‐friedlob, E., Greene, A. M., & Nennstiel, M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02970.x · Cited by 264
Improving the Quality of Care in Nursing Homes
Schechter, M. (1987) · JAMA · doi:10.1001/jama.1987.03390070103035 · Cited by 254
Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia
Rochon, P. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1090 · Cited by 242
Self-citationPsychoactive medication use in intermediate-care facility residents
Beers, M. H. (1988) · JAMA · doi:10.1001/jama.260.20.3016 · Cited by 229
Guthrie, B., McCowan, C., Davey, P. G., Simpson, C. R., Dreischulte, T., & Barnett, K. N. (2011) · BMJ · doi:10.1136/bmj.d3514 · Cited by 220
Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I., van Driel, M. L., & Christiaens, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007726.pub2 · Cited by 206
Unexplained Variation Across US Nursing Homes in Antipsychotic Prescribing Rates
Chen, Y. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.469 · Cited by 205
Changes in Antipsychotic Drug Use in Nursing Homes During Implementation of the OBRA-87 Regulations
Shorr Ronald, I. (1994) · JAMA · doi:10.1001/jama.1994.03510290040034 · Cited by 202
Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease
Devanand, D. P., Mintzer, J. E., Schultz, S. K., Andrews, H., Sultzer, D. L., de la Pena, D., Gupta, S., Colon, S., Schimming, C., Pelton, G. H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114058 · Cited by 196
Psychoactive Medication Use in Intermediate-Care Facility Residents
Beers, M. H. (1988) · JAMA · doi:10.1001/jama.1988.03410200072028 · Cited by 190
Variation in Nursing Home Antipsychotic Prescribing Rates
Rochon, P. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.676 · Cited by 183
Self-citationBallard, C. G., O'Brien, J. T., James, I. A., Mynt, P., Lana, M. M., Potkins, D., Reichelt, K., Lee, L., Swann, A., & Fossey, J. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007499 · Cited by 173
Trends in Antipsychotic Use in Dementia 1999-2007
Kales, H. C., Zivin, K., Kim, H. M., Valenstein, M. M., Chiang, C., Ignacio, R. V., Ganoczy, D. A., Cunningham, F. E., Schneider, L. S. S., & Blow, F. C. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.200 · Cited by 172
Do Atypical Antipsychotics Cause Stroke?
Herrmann, N., & Lanctôt, K. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00001 · Cited by 171
Seitz, D. P., Brisbin, S., Herrmann, N., Rapoport, M. J., Wilson, K., Gill, S. S., Rines, J., LeClair, K., & Conn, D. K. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.12.059 · Cited by 169
Self-citationCoon, J. T., Abbott, R. A., Rogers, M., Whear, R., Pearson, S., Lang, I., Cartmell, N., & Stein, K. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.06.012 · Cited by 145
Ballard, C., Orrell, M., YongZhong, S., Moniz-Cook, E., Stafford, J., Whittaker, R., Woods, B., Corbett, A., Garrod, L., Khan, Z., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010130 · Cited by 142
Gauthier, S., Patterson, C., Chertkow, H., Gordon, M., Herrmann, N., Rockwood, K., Rosa-Neto, P., & Soucy, J.-P. (2012) · Canadian Geriatrics Journal · doi:10.5770/cgj.15.49 · Cited by 137
Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US
Kamble, P., Chen, H., Sherer, J. T., & Aparasu, R. R. (2009) · Drugs & Aging · doi:10.2165/00002512-200926060-00005 · Cited by 117
The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes
Rovner, B. W., Edelman, B. A., Cox, M. P., & Shmuely, Y. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1390 · Cited by 117
Valiyeva, E., Herrmann, N., Rochon, P. A., Gill, S. S., & Anderson, G. M. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071540 · Cited by 113
Self-citationPitkälä, K. H., Laurila, J., Strandberg, T. E., & Tilvis, R. S. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000079 · Cited by 112
Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia
Nijk, R., Zuidema, S. U., & Koopmans, R. T. C. M. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008916 · Cited by 110
Hosia‐Randell, H., & l, K. H. P. (2005) · Drugs & Aging · doi:10.2165/00002512-200522090-00008 · Cited by 107
Raivio, M. M., Laurila, J. V., Strandberg, T. E., Tilvis, R. S., & Pitkälä, K. H. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31802d0b00 · Cited by 99
Gallini, A., Andrieu, S., Donohue, J. M., Oumouhou, N., Lapeyre‐Mestre, M., & Gardette, V. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.003 · Cited by 99
Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations
Shorr, R. I. (1994) · JAMA · doi:10.1001/jama.271.5.358 · Cited by 95
Martínez, C., Jones, R. W., & Rietbrock, S. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002080 · Cited by 94
Living well with dementia—development of the national dementia strategy for England
Banerjee, S. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2598 · Cited by 91
Vasudev, A., Shariff, S. Z., Liu, K., Burhan, A. M., Herrmann, N., Leonard, S., & Mamdani, M. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.07.001 · Cited by 90
Barnes, T. R. E., Banerjee, S., Collins, N., Treloar, A. J., McIntyre, S., & Paton, C. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107631 · Cited by 89
Lövheim, H., Sandman, P., Kallin, K., Karlsson, S., & Gustafson, Y. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206003930 · Cited by 88
Geriatric drug utilisation of psychotropics in Belgian nursing homes
Azermai, M., Elseviers, M. M., Petrović, M., Bortel, L. M. V., & Stichele, R. V. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1160 · Cited by 84
Zuidema, S. U., de Jonghe, J. F. M., Verhey, F. R. J., & Koopmans, R. T. C. M. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001438 · Cited by 84
Hughes, C. M., & Lapane, K. L. (2005) · Drugs & Aging · doi:10.2165/00002512-200522040-00006 · Cited by 82
Garrard, J. M., Chen, V., & Dowd, B. E. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.6.771 · Cited by 79
Mental Illness and Nursing Home Reform: OBRA-87 Ten Years Later
Snowden, M. B., & Roy‐Byrne, P. (1998) · Psychiatric Services · doi:10.1176/ps.49.2.229 · Cited by 75
Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors
Herzig, S. J., Rothberg, M. B., Guess, J. R., Stevens, J. P., Marshall, J., Gurwitz, J. H., & Marcantonio, E. R. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13943 · Cited by 73
Lövheim, H., Karlsson, S., & Gustafson, Y. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1600 · Cited by 69
Social Relationships in Later Life: A Review of the Research Literature
Phillipson, C. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199705)12:5 · Cited by 66
Psychoactive medication use in intermediate-care facility residents.
Beers, M. H., Avorn, J., Soumerai, S. B., Everitt, D. E., Sherman, D. S., & Salem, S. (1988) · PubMed · Cited by 66
Antipsychotic Use Among Nursing Home Residents
Briesacher, B. A., Tjia, J., Field, T. S., Peterson, D., & Gurwitz, J. H. (2013) · JAMA · doi:10.1001/jama.2012.211266 · Cited by 65
Konetzka, R. T., Brauner, D. J., Shega, J. W., & Werner, R. M. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12711 · Cited by 64
Is a Public Reporting Approach Appropriate for Nursing Home Care?
Stevenson, D. G. (2006) · Journal of Health Politics Policy and Law · doi:10.1215/03616878-2006-003 · Cited by 64
Factors Associated With Psychotropic Drug Usage Among Nursing Home Residents With Dementia
Kim, H., & Whall, A. L. (2006) · Nursing Research · doi:10.1097/00006199-200607000-00005 · Cited by 63
Schulze, J., van den Bussche, H., Glaeske, G., Kaduszkiewicz, H., Wiese, B., & Hoffmann, F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.001 · Cited by 56
The Pharmacotherapy of Neuropsychiatric Symptoms of Dementia
Majić, T., Pluta, J.-P., Mell, T., Aichberger, M. C., Treusch, Y., Gutzmann, H., Heinz, A., & Rapp, M. A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0320 · Cited by 51
Linden, M., Bär, T., & Helmchen, H. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000420 · Cited by 50
Lantz, M., Giambanco, V., & Buchalter, E. N. (1996) · Psychiatric Services · doi:10.1176/ps.47.9.951 · Cited by 46
The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities
Soo Borson, B., & Doane, K. W. (1997) · Psychiatric Services · doi:10.1176/ps.48.10.1289 · Cited by 46
Variability between nursing homes in prevalence of antipsychotic use in patients with dementia
Kleijer, B. C., van Marum, R. J., Frijters, D. H. M., Jansen, P. A. F., Ribbe, M. W., Egberts, T. C. G., & Heerdink, E. R. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213002019 · Cited by 46
Rhee, Y., Csernansky, J. G., Emanuel, L. L., Chang, C.-G., & Shega, J. W. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03660.x · Cited by 46
Gustafsson, M. V., Sandman, P., Karlsson, S., Gustafson, Y., & Lövheim, H. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000859 · Cited by 46
Bronskill, S. E., Rochon, P. A., Gill, S. S., Herrmann, N., Hillmer, M. P., Bell, C. M., Anderson, G., & Stukel, T. A. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181a3943f · Cited by 44
Self-citationUse of psychotropics among home‐dwelling nondemented and demented elderly
Hartikainen, S. A., Rahkonen, T., Kautiainen, H., & Sulkava, R. O. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1024 · Cited by 44
Desai, V. C. A., Heaton, P. C., & Kelton, C. M. L. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.004 · Cited by 42
Assessment of antipsychotic prescribing in Belgian nursing homes
Azermai, M., Elseviers, M. M., Petrović, M., Bortel, L. M. V., & Stichele, R. V. (2011) · International Psychogeriatrics · doi:10.1017/s104161021100024x · Cited by 40
The Use of Antidepressants in Belgian Nursing Homes
Bourgeois, J., Elseviers, M. M., Bortel, L. M. V., Petrović, M., & Stichele, R. V. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0003-6 · Cited by 39
The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use
Bowblis, J. R., Lucas, J. A., & Brunt, C. S. (2015) · Health Services Research · doi:10.1111/1475-6773.12281 · Cited by 39
Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland
Alanen, H., Finne‐Soveri, H., Noro, A., & Leinonen, E. V. J. (2006) · Age and Ageing · doi:10.1093/ageing/afl065 · Cited by 38
Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M. V., Jibson, M. D., López, O. L., Mahoney, J., Pasic, J., Tan, Z. S., et al. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.15107 · Cited by 38
Toscani, F., Giulio, P. D., Villani, D., Giunco, F., Brunelli, C., Gentile, S., Finetti, S., Charrier, L., Monti, M., & van der Steen, J. T. (2013) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0165 · Cited by 33
Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort
Arbus, C., Gardette, V., Bui, É., Cantet, C., Andrieu, S., Nourhashémi, F., Schmitt, L., & Vellas, B. J. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209990780 · Cited by 30
Cholinesterase Inhibitor Use in U.S. Nursing Homes: Results from the National Nursing Home Survey
Seitz, D. P., Gruneir, A., Conn, D. K., & Rochon, P. A. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02552.x · Cited by 27
Self-citationUse and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units
Nobili, A., Pasina, L., Trevisan, S., Riva, E., Lucca, U., Tettamanti, M., Matucci, M., & Tarantola, M. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328323aaf0 · Cited by 27
Sedative Load among Long-Term Care Facility Residents with and without Dementia
Bell, J. S., Taipale, H. T., Soini, H., & Pitkälä, K. H. (2009) · Clinical Drug Investigation · doi:10.2165/11531460-000000000-00000 · Cited by 25
Larrayadieu, A., van Kan, G. A., Piau, A., Martin, M. S., Nourhashémi, F., Rolland, Y., & Vellas, B. J. (2011) · Age and Ageing · doi:10.1093/ageing/afr032 · Cited by 25
Antipsychotic Use in Nursing Homes Varies by Psychiatric Consultant
Tjia, J., Field, T. S., Lemay, C. A., Mazor, K. M., Pandolfi, M. M., Spenard, A., Ho, S., Kanaan, A. O., Donovan, J. L., Gurwitz, J. H., et al. (2013) · Medical Care · doi:10.1097/mlr.0000000000000076 · Cited by 22
Antipsychotic prescribing patterns in care homes and relationship with dementia
Alldred, D. P., Petty, D. R., Bowie, P. C. W., Zermansky, A. G., & Raynor, D. K. (2007) · Psychiatric Bulletin · doi:10.1192/pb.bp.106.012880 · Cited by 22
Maxwell, C. J., Vu, M., Hogan, D. B., Patten, S. B., Jantzi, M., Kergoat, M., Jetté, N., Bronskill, S. E., Heckman, G. A., & Hirdes, J. P. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0083-y · Cited by 21
Self-citationProfile and variables related to antipsychotic consumption according to dementia subtypes
Calvó‐Perxas, L., de Eugenio, R., Marquez-Daniel, F., Martínez‐Fernández, R., Serena, J. L., Turbau, J., Franch, J. V., Viñas, M., Garriga, O. T., Roig, A. M., et al. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000026 · Cited by 20
Semla, T. P., Cohén, D., Freels, S. A., Paveza, G. J., Ashford, J. W., Gorelick, P. B., Luchins, D. J., & Eisdorfer, C. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04387.x · Cited by 14
Barro-Belaygues, N., van Kan, G. A., Rolland, Y., Nourhashémi, F., Soto‐Martin, M., Guyonnet, S., & Vellas, B. J. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.06.003 · Cited by 13
Stephens, P. N., Chikh, K., & Leufkens, H. G. M. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.04.013 · Cited by 12
Connelly, P., Law, E., Angus, S., & Prentice, N. P. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2313 · Cited by 11
Mental Illness and Psychotropic Medication Use in the Nursing Home
Arling, G. W., Ryther, B. J., Collins, T. M., & Zimmerman, D. R. (1991) · Journal of Aging and Health · doi:10.1177/089826439100300402 · Cited by 8
Chan, D.-C., Kasper, J. D., Black, B. S., & Rabins, P. V. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706298628 · Cited by 7
Balalle, C., Jayalath, D., Shankar, K., & Ashaye, K. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.4.f · Cited by 7
Prevalence of Psychotropic Medication Use Among Older Adults with Dementia: Meta-Analysis
Seitz, D. P., Sherman, C., & Kirkham, J. G. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.12.161 · Cited by 3
Self-citationDhawan, N., Steele, A. B., Morgan, R. O., Snow, A. L., Davila, J. A., & Kunik, M. E. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0202 · Cited by 2
Research works printed but not linked: 17
- Alzheimer Society of Canada, 2010, Rising tide: the impact of dementia on Canadian society
- Kales HC, 2015, BMJ, 350
- Schneider LS, 2006, Am J Psychiatry, 14, 191
- Lam JMC, 2009, Physicians practicing in Ontario long-term care homes: characteristics and variation in antipsychotic prescribing rates [master’s thesis]
- Majic T, 2010, Deutsches Ärzteblatt International, 107, 320
- Sapra M, American Association for Geriatric Psychiatry Annual Meeting
- 10.1136/bmjopen-2012-002080 · DOI
- 10.1016/j.euroneuro.2013.09.003 · DOI
- Declercq T, 2013, Cochrane Database Syst Rev, CD007726
- Canadian Institute for Health Information, 2016, Potentially inappropriate use of antipsychotics in long-term care
- Health Quality Ontario, 2015, Looking for balance: antipsychotic medication use in Ontario long-term care homes
- 10.1001/jama.1994.03510290040034 · DOI
- Wollstadt L, 1992, Clin Res, 40, A575
- Office of Inspector General, 2001, Psychotropic drug use in nursing homes. Report No. OEI 02-00-00490
- Berwick DM, 2003, Med Care, 41, I30
- Ivers N, 2012, Cochrane Database Syst Rev, 6, CD000259
- 10.1016/j.jamda.2011.12.059 · DOI
Cited by
Sorted by citations
Yunusa, I. U., Alsumali, A., Garba, A. E., Regestein, Q. R., & Eguale, T. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0828 · Cited by 215
Magierski, R., Sobów, T., Schwertner, E., & Religa, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01168 · Cited by 129
Tampi, R. R., & Jeste, D. V. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220508 · Cited by 112
Cummings, J. L., Pinto, L. C., de la Cruz, M. P., Fischer, C. E., Gerritsen, D. L., Grossberg, G. T., Hwang, T., Ismail, Z., Jeste, D. V., Koopmans, R. T. C. M., et al. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.09.002 · Cited by 87
Lunsky, Y., Khuu, W., Tadrous, M., Vigod, S. N., Cobigo, V., & Gomes, T. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717727240 · Cited by 79
Metadata
- Authors
- Kirkham, J., Sherman, C., Velkers, C., Maxwell, C., Gill, S., Rochon, P., & Seitz, D.
- Affiliations
- Queen's University (CA)
- University of Waterloo (CA)
- Women's College Hospital (CA)
- Corresponding author
- Seitz, Dallas
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-10-08
- Volume
- 62
- Issue
- 3
- Pages
- 170-181
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC5317021
- OpenAlex
- W2529748942
- Cited by
- 113
- References
- 100
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 10 · 2023: 14 · 2022: 19 · 2021: 18 · 2020: 14 · 2019: 14 · 2018: 3 · 2017: 2
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Consortium canadien en neurodégénérescence associée au vieillissement
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- antipsychotic drugs, dementia, neuropsychiatric symptoms, inappropriate prescribing, prescribing variation, long-term care, adverse drug reactions, prescribing policy, public reporting, clinician education, role of psychiatrists
- MeSH terms
- Dementia, Humans, Drug Prescriptions, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
